Ceruvia Lifesciences

Ceruvia Lifesciences, founded in 2017, is a clinical-stage biopharmaceutical company with the mission of improving the lives of patients with neurological and psychiatric disorders. Ceruvia, established by Carey Turnbull, is dedicated to the development and commercialization of neuro-transformative drugs, providing meaningful relief for patients suffering from headaches, obsessive-compulsive disorder, and substance abuse disorders. Ceruvia is currently conducting clinical research to help them restore their most fulfilling lives.